Karen Eves

Bezlotoxumab for Prevention of Recurrent <i>Clostridium difficile</i> Infection

Mark H. Wilcox, Dale N. Gerding, Ian R. Poxton et al. · New England Journal of Medicine · 2017 · 850 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

Dale N. Gerding, Ciarán P. Kelly, Galia Rahav et al. · Clinical Infectious Diseases · 2018 · 206 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children

Henry R. Shinefield, Steve Black, Laura Digilio et al. · The Pediatric Infectious Disease Journal · 2005 · 124 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial

Jean‐Michel Molina, Yazdan Yazdanpanah, Alejandro Afani Saud et al. · The Lancet HIV · 2021 · 44 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial

Jean‐Michel Molina, Giuliano Rizzardini, Catherine Orrell et al. · The Lancet HIV · 2024 · 29 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +14